Psoralen-protein photochemistry--a forgotten field.
8-Methoxypsoralen in combination with long wavelength ultraviolet light is employed for the treatment of several cutaneous disorders, such as psoriasis, vitiligo and mycosis fungoides. It is common to attribute the efficacy of the photochemotherapy to the formation of psoralen DNA photoadducts. Thus, the main research effort has been directed towards the elucidation of nucleic acid photochemistry and related subsequent events (mutagenicity, toxicity). However, psoralens have been shown to undergo photoaddition reactions with other cellular components. In this review the status of psoralen-DNA photobiology is briefly summarized. The main focus, however, is on a survey of psoralen photochemical modification of proteins and the ways by which these additional photobiological events can impact the antigenicity and potentially immunogenicity of treated cells. Some preliminary results show the extent of psoralen-amino acid photoadduct formation and their impact on enzymatic processing.
Schmitt
I M
IM
Yale University Photobiology Laboratory, Department of Dermatology, New Haven CT 06510.
Chimenti
S
S
Gasparro
F P
FP
D001665:Binding Sites; D004247:DNA / Q000378:metabolism; D018736:DNA Adducts / Q000737:chemistry; D011564:Furocoumarins / Q000737:chemistry* / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D008730:Methoxsalen / Q000737:chemistry*; D016328:NF-kappa B / Q000378:metabolism; D010455:Peptides / Q000737:chemistry*; D010777:Photochemistry; D011485:Protein Binding; D011506:Proteins / Q000737:chemistry*; D014157:Transcription Factors / Q000378:metabolism*
D018736:DNA Adducts; D011564:Furocoumarins; D016328:NF-kappa B; D010455:Peptides; D011506:Proteins; D014157:Transcription Factors; D004247:DNA; D008730:Methoxsalen